Preventive treatment of pregnant women at high postpartum psychosis risk

March 9, 2012

(Medical Xpress) -- Twenty-nine pregnant women with a history of psychotic symptoms after previous deliveries, but not at other times, all remained stable without medication throughout their current pregnancies. Those who then began taking lithium or an antipsychotic within hours after delivery remained free of relapse after childbirth.

In contrast, relapse during pregnancy was common in women with bipolar disorder, especially in women who did not take medication during pregnancy. After delivery, most of the women with bipolar disorder took medication, but relapse nevertheless occurred in six of the ten who had experienced mood episodes during pregnancy.

This study of 70 women will be published online on March 8, 2012, at AJP in Advance, the ahead-of-print website of The (AJP), the official journal of the . The women were treated in the Peripartum of Veerle Bergink, M.D., and colleagues of Erasmus Medical Center in Rotterdam, the Netherlands. They were considered to be at high risk of postpartum psychosis because of either bipolar disorder or a history of postpartum psychosis only, without manic or at other times.

The pregnant women made their own decisions regarding whether to take medication during pregnancy and the . They were given information and recommendations regarding specific drugs and treatment options, and those who were taking a mood stabilizer at the time of evaluation were advised to continue during pregnancy.

Dr. Bergink stated, “Up to now, physicians haven’t known when to start medication to prevent postpartum psychosis. Many have thought that it has to start before delivery, but that exposes the fetus to possible adverse effects. Now women who have a history of psychosis limited to the postpartum period may be able to avoid that risk. On the other hand, in women with , medication during pregnancy appears critically important to maintain mood stability during pregnancy and to minimize the high risk of postpartum relapse.”

Robert Freedman, M.D., AJP Editor-in-Chief commented: “This unique study does not establish new guidelines for treatment, but it gives doctors and patients important data for their decisions on the benefits and risks for preventive treatment during pregnancy.”

The study was performed at the Erasmus Medical Center in Rotterdam, the Netherlands.

Explore further: Study: Breastfeeding does not protect against MS relapses

More information: ajp.psychiatryonline.org/AJPInAdvance.aspx

Related Stories

Study: Breastfeeding does not protect against MS relapses

July 6, 2011
New research finds breastfeeding doesn't appear to protect against multiple sclerosis (MS) relapses, despite previous studies suggesting there may be a protective role. The research is published in the July 6, 2011, online ...

Stopping meds during pregnancy does not increase risk of depression

September 9, 2011
(Medical Xpress) -- Women who discontinue using antidepressants during pregnancy do not appear to have greater risk of having a depressive episode during and after term than those who continue using medications, a new Yale ...

Pre-Existing hypertension linked to depression in pregnant women

November 11, 2011
Women with a history of high blood pressure before getting pregnant have a higher risk of depression than women who develop pregnancy-related hypertension, according to a new study.

Recommended for you

For a better 'I,' there needs to be a supportive 'we'

September 25, 2017
If you're one of those lucky individuals with high motivation and who actively pursues personal growth goals, thank your family and friends who support you.

Babies can learn that hard work pays off

September 21, 2017
If at first you don't succeed, try, try again. A new study from MIT reveals that babies as young as 15 months can learn to follow this advice. The researchers found that babies who watched an adult struggle at two different ...

Study links brain inflammation to suicidal thinking in depression

September 21, 2017
Patients with major depressive disorder (MDD) have increased brain levels of a marker of microglial activation, a sign of inflammation, according to a new study in Biological Psychiatry by researchers at the University of ...

Oxytocin turns up the volume of your social environment

September 20, 2017
Before you shop for the "cuddle" hormone oxytocin to relieve stress and enhance your social life, read this: a new study from the University of California, Davis, suggests that sometimes, blocking the action of oxytocin in ...

Researchers develop new tool to assess individual's level of wisdom

September 20, 2017
Researchers at University of San Diego School of Medicine have developed a new tool called the San Diego Wisdom Scale (SD-WISE) to assess an individual's level of wisdom, based upon a conceptualization of wisdom as a trait ...

Alcohol use affects levels of cholesterol regulator through epigenetics

September 20, 2017
In an analysis of the epigenomes of people and mice, researchers at Johns Hopkins Medicine and the National Institutes of Health report that drinking alcohol may induce changes to a cholesterol-regulating gene.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.